{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:40:30Z","timestamp":1782470430892,"version":"3.54.5"},"reference-count":109,"publisher":"Journal of Biomedical Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Biomed Res"],"published-print":{"date-parts":[[2021]]},"DOI":"10.7555\/jbr.34.20200108","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T02:57:39Z","timestamp":1609901859000},"page":"1","source":"Crossref","is-referenced-by-count":24,"title":["nNOS-mediated protein-protein interactions: promising targets for treating neurological and neuropsychiatric disorders"],"prefix":"10.7555","volume":"35","author":[{"given":"Yuanyuan","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongya","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4380","reference":[{"key":"key-10.7555\/JBR.34.20200108-1","doi-asserted-by":"publisher","unstructured":"Moos WH, Maneta E, Pinkert CA, et al.  Epigenetic treatment of neuropsychiatric disorders: autism and schizophrenia[J]. <i>Drug Dev Res, <\/i>2016, 77(2): 53\u201372.","DOI":"10.1002\/ddr.21295"},{"key":"key-10.7555\/JBR.34.20200108-2","doi-asserted-by":"publisher","unstructured":"D\u017eolji\u0107 E, Grbatini\u0107 I, Kosti\u0107 V.  Why is nitric oxide important for our brain?[J]. <i>Funct Neurol, <\/i>2015, 30(3): 159\u2013163.","DOI":"10.11138\/fneur\/2015.30.3.159"},{"key":"key-10.7555\/JBR.34.20200108-3","doi-asserted-by":"publisher","unstructured":"Zhou L, Zhu DY.  Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications[J]. <i>Nitric Oxide, <\/i>2009, 20(4): 223\u2013230.","DOI":"10.1016\/j.niox.2009.03.001"},{"key":"key-10.7555\/JBR.34.20200108-4","doi-asserted-by":"publisher","unstructured":"Bredt DS.  Endogenous nitric oxide synthesis: biological functions and pathophysiology[J]. <i>Free Radic Res, <\/i>1999, 31(6): 577\u2013596.","DOI":"10.1080\/10715769900301161"},{"key":"key-10.7555\/JBR.34.20200108-5","doi-asserted-by":"publisher","unstructured":"Luo CX, Zhu DY.  Research progress on neurobiology of neuronal nitric oxide synthase[J]. <i>Neurosci Bull, <\/i>2011, 27(1): 23\u201335.","DOI":"10.1007\/s12264-011-1038-0"},{"key":"key-10.7555\/JBR.34.20200108-6","doi-asserted-by":"publisher","unstructured":"Zhou QG, Zhu XH, Nemes AD, et al.  Neuronal nitric oxide synthase and affective disorders[J]. <i>IBRO Rep, <\/i>2018, 5: 116\u2013132.","DOI":"10.1016\/j.ibror.2018.11.004"},{"key":"key-10.7555\/JBR.34.20200108-7","doi-asserted-by":"publisher","unstructured":"Chanrion B, Mannoury la Cour C, Bertaso F, et al.  Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity[J]. <i>Proc Natl Acad Sci U S A, <\/i>2007, 104(19): 8119\u20138124.","DOI":"10.1073\/pnas.0610964104"},{"key":"key-10.7555\/JBR.34.20200108-8","doi-asserted-by":"publisher","unstructured":"Langeberg LK, Scott JD.  Signalling scaffolds and local organization of cellular behaviour[J]. <i>Nat Rev Mol Cell Biol, <\/i>2015, 16(4): 232\u2013244.","DOI":"10.1038\/nrm3966"},{"key":"key-10.7555\/JBR.34.20200108-9","doi-asserted-by":"publisher","unstructured":"Doyle DA, Lee A, Lewis J, et al.  Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ[J]. <i>Cell, <\/i>1996, 85(7): 1067\u20131076.","DOI":"10.1016\/S0092-8674(00)81307-0"},{"key":"key-10.7555\/JBR.34.20200108-10","doi-asserted-by":"publisher","unstructured":"Feng W, Zhang MJ.  Organization and dynamics of PDZ-domain-related supramodules in the postsynaptic density[J]. <i>Nat Rev Neurosci, <\/i>2009, 10(2): 87\u201399.","DOI":"10.1038\/nrn2540"},{"key":"key-10.7555\/JBR.34.20200108-11","doi-asserted-by":"publisher","unstructured":"Manjunath GP, Ramanujam PL, Galande S.  Structure function relations in PDZ-domain-containing proteins: implications for protein networks in cellular signalling[J]. <i>J Biosci, <\/i>2018, 43(1): 155\u2013171.","DOI":"10.1007\/s12038-017-9727-0"},{"key":"key-10.7555\/JBR.34.20200108-12","doi-asserted-by":"publisher","unstructured":"Zhu LJ, Li TY, Luo CX, et al.  CAPON-nNOS coupling can serve as a target for developing new anxiolytics[J]. <i>Nat Med, <\/i>2014, 20(9): 1050\u20131054.","DOI":"10.1038\/nm.3644"},{"key":"key-10.7555\/JBR.34.20200108-13","doi-asserted-by":"publisher","unstructured":"Cui ZM, Lv QS, Yan MJ, et al.  Elevated expression of CAPON and neuronal nitric oxide synthase in the sciatic nerve of rats following constriction injury[J]. <i>Vet J, <\/i>2011, 187(3): 374\u2013380.","DOI":"10.1016\/j.tvjl.2010.01.014"},{"key":"key-10.7555\/JBR.34.20200108-14","doi-asserted-by":"publisher","unstructured":"Stricker NL, Christopherson KS, Yi BA, et al.  PDZ domain of neuronal nitric oxide synthase recognizes novel C-terminal peptide sequences[J]. <i>Nat Biotechnol, <\/i>1997, 15(4): 336\u2013342.","DOI":"10.1038\/nbt0497-336"},{"key":"key-10.7555\/JBR.34.20200108-15","doi-asserted-by":"publisher","unstructured":"Tochio H, Zhang Q, Mandal P, et al.  Solution structure of the extended neuronal nitric oxide synthase PDZ domain complexed with an associated peptide[J]. <i>Nat Struct Biol, <\/i>1999, 6(5): 417\u2013421.","DOI":"10.1038\/8216"},{"key":"key-10.7555\/JBR.34.20200108-16","doi-asserted-by":"publisher","unstructured":"Zhou L, Li F, Xu HB, et al.  Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95[J]. <i>Nat Med, <\/i>2010, 16(12): 1439\u20131443.","DOI":"10.1038\/nm.2245"},{"key":"key-10.7555\/JBR.34.20200108-17","doi-asserted-by":"publisher","unstructured":"Ran X, Gestwicki JE.  Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area[J]. <i>Curr Opin Chem Biol, <\/i>2018, 44: 75\u201386.","DOI":"10.1016\/j.cbpa.2018.06.004"},{"key":"key-10.7555\/JBR.34.20200108-18","doi-asserted-by":"publisher","unstructured":"Manso H, Krug T, Sobral J, et al.  Variants within the nitric oxide synthase 1 gene are associated with stroke susceptibility[J]. <i>Atherosclerosis, <\/i>2012, 220(2): 443\u2013448.","DOI":"10.1016\/j.atherosclerosis.2011.11.011"},{"key":"key-10.7555\/JBR.34.20200108-19","doi-asserted-by":"publisher","unstructured":"Dai YJ, He ZY, Sui RB, et al.  Association of <i>nNOS<\/i> gene polymorphism with ischemic stroke in Han Chinese of North China[J]. <i>Sci World J, <\/i>2013, 2013: 891581.","DOI":"10.1155\/2013\/891581"},{"key":"key-10.7555\/JBR.34.20200108-20","doi-asserted-by":"publisher","unstructured":"Liu HT, Li J, Zhao FY, et al.  Nitric oxide synthase in hypoxic or ischemic brain injury[J]. <i>Rev Neurosci, <\/i>2015, 26(1): 105\u2013117.","DOI":"10.1515\/revneuro-2014-0041"},{"key":"key-10.7555\/JBR.34.20200108-21","doi-asserted-by":"publisher","unstructured":"Eliasson MJL, Huang ZH, Ferrante RJ, et al.  Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage[J]. <i>J Neurosci, <\/i>1999, 19(14): 5910\u20135918.","DOI":"10.1523\/JNEUROSCI.19-14-05910.1999"},{"key":"key-10.7555\/JBR.34.20200108-22","doi-asserted-by":"publisher","unstructured":"Samdani AF, Dawson TM, Dawson VL.  Nitric oxide synthase in models of focal ischemia[J]. <i>Stroke, <\/i>1997, 28(6): 1283\u20131288.","DOI":"10.1161\/01.STR.28.6.1283"},{"key":"key-10.7555\/JBR.34.20200108-23","doi-asserted-by":"publisher","unstructured":"Luo CX, Zhu XJ, Zhou QG, et al.  Reduced neuronal nitric oxide synthase is involved in ischemia-induced hippocampal neurogenesis by up-regulating inducible nitric oxide synthase expression[J]. <i>J Neurochem, <\/i>2007, 103(5): 1872\u20131882.","DOI":"10.1111\/j.1471-4159.2007.04915.x"},{"key":"key-10.7555\/JBR.34.20200108-24","doi-asserted-by":"publisher","unstructured":"Tochio H, Mok YK, Zhang Q, et al.  Formation of nNOS\/PSD-95 PDZ dimer requires a preformed \u03b2-finger structure from the nNOS PDZ domain[J]. <i>J Mol Biol, <\/i>2000, 303(3): 359\u2013370.","DOI":"10.1006\/jmbi.2000.4148"},{"key":"key-10.7555\/JBR.34.20200108-25","doi-asserted-by":"publisher","unstructured":"Wang ZY, Zhao Y, Jiang Y, et al.  Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system[J]. <i>Sci Rep, <\/i>2015, 5: 12651.","DOI":"10.1038\/srep12651"},{"key":"key-10.7555\/JBR.34.20200108-26","doi-asserted-by":"publisher","unstructured":"Chen D, Zhao T, Ni K, et al.  Metabolic investigation on ZL006 for the discovery of a potent prodrug for the treatment of cerebral ischemia[J]. <i>Bioorg Med Chem Lett, <\/i>2016, 26(9): 2152\u20132155.","DOI":"10.1016\/j.bmcl.2016.03.074"},{"key":"key-10.7555\/JBR.34.20200108-27","doi-asserted-by":"publisher","unstructured":"Zhao Y, Jiang Y, Lv W, et al.  Dual targeted nanocarrier for brain ischemic stroke treatment[J]. <i>J Control Release, <\/i>2016, 233: 64\u201371.","DOI":"10.1016\/j.jconrel.2016.04.038"},{"key":"key-10.7555\/JBR.34.20200108-28","doi-asserted-by":"publisher","unstructured":"Del Arroyo AG, Hadjihambi A, Sanchez J, et al.  NMDA receptor modulation of glutamate release in activated neutrophils[J]. <i>EBioMedicine, <\/i>2019, 47: 457\u2013469.","DOI":"10.1016\/j.ebiom.2019.08.004"},{"key":"key-10.7555\/JBR.34.20200108-29","doi-asserted-by":"publisher","unstructured":"David J, O'Toole E, O'Reilly K, et al.  Inhibitors of the NMDA-nitric oxide signaling pathway protect against neuronal atrophy and synapse loss provoked by l-alpha aminoadipic acid-treated astrocytes[J]. <i>Neuroscience, <\/i>2018, 392: 38\u201356.","DOI":"10.1016\/j.neuroscience.2018.09.023"},{"key":"key-10.7555\/JBR.34.20200108-30","doi-asserted-by":"publisher","unstructured":"Luo CX, Lin YH, Qian XD, et al.  Interaction of nNOS with PSD-95 negatively controls regenerative repair after stroke[J]. <i>J Neurosci, <\/i>2014, 34(40): 13535\u201313548.","DOI":"10.1523\/JNEUROSCI.1305-14.2014"},{"key":"key-10.7555\/JBR.34.20200108-31","doi-asserted-by":"publisher","unstructured":"Wang DL, Qian XD, Lin YH, et al.  ZL006 promotes migration and differentiation of transplanted neural stem cells in male rats after stroke[J]. <i>J Neurosci Res, <\/i>2017, 95(12): 2409\u20132419.","DOI":"10.1002\/jnr.24068"},{"key":"key-10.7555\/JBR.34.20200108-32","doi-asserted-by":"publisher","unstructured":"Lin YH, Dong J, Tang Y, et al.  Opening a new time window for treatment of stroke by targeting HDAC2[J]. <i>J Neurosci, <\/i>2017, 37(28): 6712\u20136728.","DOI":"10.1523\/JNEUROSCI.0341-17.2017"},{"key":"key-10.7555\/JBR.34.20200108-33","doi-asserted-by":"publisher","unstructured":"Tang Y, Lin YH, Ni HY, et al.  Inhibiting histone deacetylase 2 (HDAC2) promotes functional recovery from stroke[J]. <i>J Am Heart Assoc, <\/i>2017, 6(10): e007236.","DOI":"10.1161\/JAHA.117.007236"},{"key":"key-10.7555\/JBR.34.20200108-34","doi-asserted-by":"publisher","unstructured":"Lin YH, Yao MC, Wu HY, et al.  HDAC2 (Histone deacetylase 2): a critical factor in environmental enrichment-mediated stroke recovery[J]. <i>J Neurochem, <\/i>2020. doi: 10.1111\/jnc.15043. [Epub ahead of print","DOI":"10.1111\/jnc.15043"},{"key":"key-10.7555\/JBR.34.20200108-35","doi-asserted-by":"publisher","unstructured":"Clarkson AN, Huang BS, MacIsaac SE, et al.  Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke[J]. <i>Nature, <\/i>2010, 468(7321): 305\u2013309.","DOI":"10.1038\/nature09511"},{"key":"key-10.7555\/JBR.34.20200108-36","doi-asserted-by":"publisher","unstructured":"Lin YH, Liang HY, Xu K, et al.  Dissociation of nNOS from PSD-95 promotes functional recovery after cerebral ischaemia in mice through reducing excessive tonic GABA release from reactive astrocytes[J]. <i>J Pathol, <\/i>2018, 244(2): 176\u2013188.","DOI":"10.1002\/path.4999"},{"key":"key-10.7555\/JBR.34.20200108-37","doi-asserted-by":"publisher","unstructured":"Qu WR, Liu NK, Wu XB, et al.  Disrupting nNOS-PSD95 interaction improves neurological and cognitive recoveries after traumatic brain injury[J]. <i>Cereb Cortex, <\/i>2020, 30(7): 3859\u20133871.","DOI":"10.1093\/cercor\/bhaa002"},{"key":"key-10.7555\/JBR.34.20200108-38","doi-asserted-by":"publisher","unstructured":"Liu SG, Wang YM, Zhang YJ, et al.  ZL006 protects spinal cord neurons against ischemia-induced oxidative stress through AMPK-PGC-1\u03b1-Sirt3 pathway[J]. <i>Neurochem Int, <\/i>2017, 108: 230\u2013237.","DOI":"10.1016\/j.neuint.2017.04.005"},{"key":"key-10.7555\/JBR.34.20200108-39","doi-asserted-by":"publisher","unstructured":"Li LL, Ginet V, Liu XN, et al.  The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death[J]. <i>J Neurosci, <\/i>2013, 33(19): 8185\u20138201.","DOI":"10.1523\/JNEUROSCI.4578-12.2013"},{"key":"key-10.7555\/JBR.34.20200108-40","doi-asserted-by":"publisher","unstructured":"Jaffrey SR, Snowman AM, Eliasson MJL, et al.  CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95[J]. <i>Neuron, <\/i>1998, 20(1): 115\u2013124.","DOI":"10.1016\/S0896-6273(00)80439-0"},{"key":"key-10.7555\/JBR.34.20200108-41","doi-asserted-by":"publisher","unstructured":"Jiang J, Yan M, Lv Q, et al.  Inhibition of nitric oxide-induced nuclear localization of CAPON by NMDA receptor antagonist in cultured rat primary astrocytes[J]. <i>Neurochem Int, <\/i>2010, 56(4): 561\u2013568.","DOI":"10.1016\/j.neuint.2009.12.019"},{"key":"key-10.7555\/JBR.34.20200108-42","doi-asserted-by":"publisher","unstructured":"Ni HY, Song YX, Lin YH, et al.  Dissociating nNOS (neuronal NO synthase)-CAPON (Carboxy-terminal postsynaptic density-95\/discs large\/zona occludens-1 ligand of nNOS) interaction promotes functional recovery after stroke via enhanced structural neuroplasticity[J]. <i>Stroke, <\/i>2019, 50(3): 728\u2013737.","DOI":"10.1161\/STROKEAHA.118.022647"},{"key":"key-10.7555\/JBR.34.20200108-43","doi-asserted-by":"publisher","unstructured":"Holmes D.  The pain drain[J]. <i>Nature, <\/i>2016, 535(7611): S2\u2013S3.","DOI":"10.1038\/535S2a"},{"key":"key-10.7555\/JBR.34.20200108-44","doi-asserted-by":"publisher","unstructured":"South SM, Kohno T, Kaspar BK, et al.  A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain[J]. <i>J Neurosci, <\/i>2003, 23(12): 5031\u20135040.","DOI":"10.1523\/JNEUROSCI.23-12-05031.2003"},{"key":"key-10.7555\/JBR.34.20200108-45","doi-asserted-by":"publisher","unstructured":"Zhou HY, Chen SR, Pan HL.  Targeting <i>N<\/i>-methyl-D-aspartate receptors for treatment of neuropathic pain[J]. <i>Expert Rev Clin Pharmacol, <\/i>2011, 4(3): 379\u2013388.","DOI":"10.1586\/ecp.11.17"},{"key":"key-10.7555\/JBR.34.20200108-46","doi-asserted-by":"publisher","unstructured":"Pal HR, Berry N, Kumar R, et al.  Ketamine dependence[J]. <i>Anaesth Intensive Care, <\/i>2002, 30(3): 382\u2013384.","DOI":"10.1177\/0310057X0203000323"},{"key":"key-10.7555\/JBR.34.20200108-47","doi-asserted-by":"publisher","unstructured":"Carey LM, Lee WH, Gutierrez T, et al.  Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats[J]. <i>Neuroscience, <\/i>2017, 349: 303\u2013317.","DOI":"10.1016\/j.neuroscience.2017.02.055"},{"key":"key-10.7555\/JBR.34.20200108-48","doi-asserted-by":"publisher","unstructured":"Lee WH, Xu ZL, Ashpole NM, et al.  Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics[J]. <i>Neuropharmacology, <\/i>2015, 97: 464\u2013475.","DOI":"10.1016\/j.neuropharm.2015.05.038"},{"key":"key-10.7555\/JBR.34.20200108-49","doi-asserted-by":"publisher","unstructured":"Cai WH, Wu SG, Pan ZQ, et al.  Disrupting interaction of PSD-95 with nNOS attenuates hemorrhage-induced thalamic pain[J]. <i>Neuropharmacology, <\/i>2018, 141: 238\u2013248.","DOI":"10.1016\/j.neuropharm.2018.09.003"},{"key":"key-10.7555\/JBR.34.20200108-50","doi-asserted-by":"publisher","unstructured":"Deyama S, Sugano Y, Mori S, et al.  Activation of the NMDA receptor-neuronal nitric oxide synthase pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain[J]. <i>Neuropharmacology, <\/i>2017, 118: 59\u201368.","DOI":"10.1016\/j.neuropharm.2017.03.008"},{"key":"key-10.7555\/JBR.34.20200108-51","doi-asserted-by":"publisher","unstructured":"Lee WH, Li LL, Chawla A, et al.  Disruption of nNOS-NOS1AP protein-protein interactions suppresses neuropathic pain in mice[J]. <i>Pain, <\/i>2018, 159(5): 849\u2013863.","DOI":"10.1097\/j.pain.0000000000001152"},{"key":"key-10.7555\/JBR.34.20200108-52","doi-asserted-by":"publisher","unstructured":"Lee WH, Carey LM, Li LL, et al.  ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability[J]. <i>Mol Pain, <\/i>2018, 14: 1\u201317.","DOI":"10.1177\/1744806918801224"},{"key":"key-10.7555\/JBR.34.20200108-53","doi-asserted-by":"publisher","unstructured":"Li J, Zhang L, Xu C, et al.  Prolonged use of NMDAR antagonist develops analgesic tolerance in neuropathic pain <i>via<\/i> nitric oxide reduction-induced GABAergic disinhibition[J]. <i>Neurotherapeutics, <\/i>2020, 17(3): 1016\u20131030.","DOI":"10.1007\/s13311-020-00883-w"},{"key":"key-10.7555\/JBR.34.20200108-54","doi-asserted-by":"publisher","unstructured":"Atri A.  The Alzheimer's Disease clinical spectrum: diagnosis and management[J]. <i>Med Clin North Am, <\/i>2019, 103(2): 263\u2013293.","DOI":"10.1016\/j.mcna.2018.10.009"},{"key":"key-10.7555\/JBR.34.20200108-55","doi-asserted-by":"publisher","unstructured":"Weller J, Budson A.  Current understanding of Alzheimer's disease diagnosis and treatment[J]. <i>F1000Res, <\/i>2018, 7: 1161.","DOI":"10.12688\/f1000research.14506.1"},{"key":"key-10.7555\/JBR.34.20200108-56","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zhu Z, Liang HY, et al.  nNOS-CAPON interaction mediates amyloid-\u03b2-induced neurotoxicity, especially in the early stages[J]. <i>Aging Cell, <\/i>2018, 17(3): e12754.","DOI":"10.1111\/acel.12754"},{"key":"key-10.7555\/JBR.34.20200108-57","doi-asserted-by":"publisher","unstructured":"Hashimoto S, Matsuba Y, Kamano N, et al.  Author Correction: tau binding protein CAPON induces tau aggregation and neurodegeneration[J]. <i>Nat Commun, <\/i>2019, 10(1): 2964.","DOI":"10.1038\/s41467-019-10990-8"},{"key":"key-10.7555\/JBR.34.20200108-58","doi-asserted-by":"publisher","unstructured":"Tao WY, Yu LJ, Jiang S, et al.  Neuroprotective effects of ZL006 in A\u03b2<sub>1-42<\/sub>-treated neuronal cells[J]. <i>Neural Regen Res, <\/i>2020, 15(12): 2296\u20132305.","DOI":"10.4103\/1673-5374.285006"},{"key":"key-10.7555\/JBR.34.20200108-59","doi-asserted-by":"publisher","unstructured":"Smith AE, Xu ZL, Lai YY, et al.  Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors[J]. <i>Behav Brain Res, <\/i>2016, 305: 23\u201329.","DOI":"10.1016\/j.bbr.2016.02.021"},{"key":"key-10.7555\/JBR.34.20200108-60","unstructured":"Young J, Mendoza M.  Parkinson's disease: a treatment guide[J]. <i>J Fam Pract, <\/i>2018, 67(5): 276, 279, 284, 286."},{"key":"key-10.7555\/JBR.34.20200108-61","doi-asserted-by":"publisher","unstructured":"Dauer W, Przedborski S.  Parkinson's disease: mechanisms and models[J]. <i>Neuron, <\/i>2003, 39(6): 889\u2013909.","DOI":"10.1016\/S0896-6273(03)00568-3"},{"key":"key-10.7555\/JBR.34.20200108-62","doi-asserted-by":"crossref","unstructured":"Jiang PE, Lang QH, Yu QY, et al.  Behavioral assessments of spontaneous locomotion in a murine MPTP-induced Parkinson's disease model[J]. <i>J Vis Exp, <\/i>2019, (143): e58653.","DOI":"10.3791\/58653"},{"key":"key-10.7555\/JBR.34.20200108-63","doi-asserted-by":"publisher","unstructured":"Hu W, Guan LS, Dang XB, et al.  Small-molecule inhibitors at the PSD-95\/nNOS interface attenuate MPP<sup>+<\/sup>-induced neuronal injury through Sirt3 mediated inhibition of mitochondrial dysfunction[J]. <i>Neurochem Int, <\/i>2014, 79: 57\u201364.","DOI":"10.1016\/j.neuint.2014.10.005"},{"key":"key-10.7555\/JBR.34.20200108-64","doi-asserted-by":"crossref","unstructured":"Millan MJ.  The role of monoamines in the actions of established and \"novel\" antidepressant agents: a critical review[J]. <i>Eur J Pharmacol, <\/i>2004, 500(1\u20133): 371\u2013384.","DOI":"10.1016\/j.ejphar.2004.07.038"},{"key":"key-10.7555\/JBR.34.20200108-65","doi-asserted-by":"publisher","unstructured":"Yohn CN, Gergues MM, Samuels BA.  The role of 5-HT receptors in depression[J]. <i>Mol Brain, <\/i>2017, 10(1): 28.","DOI":"10.1186\/s13041-017-0306-y"},{"key":"key-10.7555\/JBR.34.20200108-66","doi-asserted-by":"publisher","unstructured":"Baranyi A, Amouzadeh-Ghadikolai O, Rothenh\u00e4usler HB, et al.  Nitric oxide-related biological pathways in patients with major depression[J]. <i>PLoS One, <\/i>2015, 10(11): e0143397.","DOI":"10.1371\/journal.pone.0143397"},{"key":"key-10.7555\/JBR.34.20200108-67","doi-asserted-by":"publisher","unstructured":"Ostadhadi S, Khan MI, Norouzi-Javidan A, et al.  Involvement of NMDA receptors and <sub>L<\/sub>-arginine\/nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test[J]. <i>Brain Res Bull, <\/i>2016, 122: 62\u201370.","DOI":"10.1016\/j.brainresbull.2016.03.004"},{"key":"key-10.7555\/JBR.34.20200108-68","doi-asserted-by":"publisher","unstructured":"Zhou QG, Hu Y, Hua Y, et al.  Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis[J]. <i>J Neurochem, <\/i>2007, 103(5): 1843\u20131854.","DOI":"10.1111\/j.1471-4159.2007.04914.x"},{"key":"key-10.7555\/JBR.34.20200108-69","doi-asserted-by":"publisher","unstructured":"Lupien SJ, McEwen BS, Gunnar MR, et al.  Effects of stress throughout the lifespan on the brain, behaviour and cognition[J]. <i>Nat Rev Neurosci, <\/i>2009, 10(6): 434\u2013445.","DOI":"10.1038\/nrn2639"},{"key":"key-10.7555\/JBR.34.20200108-70","doi-asserted-by":"publisher","unstructured":"Joseph DN, Whirledge S.  Stress and the HPA axis: balancing homeostasis and fertility[J]. <i>Int J Mol Sci, <\/i>2017, 18(10): 2224.","DOI":"10.3390\/ijms18102224"},{"key":"key-10.7555\/JBR.34.20200108-71","doi-asserted-by":"publisher","unstructured":"Zhou QG, Zhu LJ, Chen C, et al.  Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor[J]. <i>J Neurosci, <\/i>2011, 31(21): 7579\u20137590.","DOI":"10.1523\/JNEUROSCI.0004-11.2011"},{"key":"key-10.7555\/JBR.34.20200108-72","doi-asserted-by":"publisher","unstructured":"Zhu LJ, Liu MY, Li H, et al.  The different roles of glucocorticoids in the hippocampus and hypothalamus in chronic stress-induced HPA axis hyperactivity[J]. <i>PLoS One, <\/i>2014, 9(5): e97689.","DOI":"10.1371\/journal.pone.0097689"},{"key":"key-10.7555\/JBR.34.20200108-73","doi-asserted-by":"publisher","unstructured":"Hu Y, Wu DL, Luo CX, et al.  Hippocampal nitric oxide contributes to sex difference in affective behaviors[J]. <i>Proc Natl Acad Sci U S A, <\/i>2012, 109(35): 14224\u201314229.","DOI":"10.1073\/pnas.1207461109"},{"key":"key-10.7555\/JBR.34.20200108-74","doi-asserted-by":"publisher","unstructured":"Doucet MV, Levine H, Dev KK, et al.  Small-molecule inhibitors at the PSD-95\/nNOS interface have antidepressant-like properties in mice[J]. <i>Neuropsychopharmacology, <\/i>2013, 38(8): 1575\u20131584.","DOI":"10.1038\/npp.2013.57"},{"key":"key-10.7555\/JBR.34.20200108-75","doi-asserted-by":"publisher","unstructured":"Dean E.  Anxiety[J]. <i>Nurs Stand, <\/i>2016, 30(46): 15.","DOI":"10.7748\/ns.30.46.15.s17"},{"key":"key-10.7555\/JBR.34.20200108-76","doi-asserted-by":"publisher","unstructured":"Carlezon WA Jr, Duman RS, Nestler EJ.  The many faces of CREB[J]. <i>Trends Neurosci, <\/i>2005, 28(8): 436\u2013445.","DOI":"10.1016\/j.tins.2005.06.005"},{"key":"key-10.7555\/JBR.34.20200108-77","doi-asserted-by":"publisher","unstructured":"Zhang J, Huang XY, Ye ML, et al.  Neuronal nitric oxide synthase alteration accounts for the role of 5-HT<sub>1A<\/sub> receptor in modulating anxiety-related behaviors[J]. <i>J Neurosci, <\/i>2010, 30(7): 2433\u20132441.","DOI":"10.1523\/JNEUROSCI.5880-09.2010"},{"key":"key-10.7555\/JBR.34.20200108-78","doi-asserted-by":"publisher","unstructured":"Zhang J, Cai CY, Wu HY, et al.  Correction: corrigendum: CREB-mediated synaptogenesis and neurogenesis is crucial for the role of 5-HT1a receptors in modulating anxiety behaviors[J]. <i>Sci Rep, <\/i>2017, 7: 43405.","DOI":"10.1038\/srep43405"},{"key":"key-10.7555\/JBR.34.20200108-79","doi-asserted-by":"publisher","unstructured":"Cai CY, Wu HY, Luo CX, et al.  Extracellular regulated protein kinaseis critical for the role of 5-HT1a receptor in modulating nNOS expression and anxiety-related behaviors[J]. <i>Behav Brain Res, <\/i>2019, 357\u2013358: 88\u201397.","DOI":"10.1016\/j.bbr.2017.12.017"},{"key":"key-10.7555\/JBR.34.20200108-80","doi-asserted-by":"publisher","unstructured":"Zlatkovi\u0107 J, Filipovi\u0107 D.  Chronic social isolation induces NF-\u03baB activation and upregulation of iNOS protein expression in rat prefrontal cortex[J]. <i>Neurochem Int, <\/i>2013, 63(3): 172\u2013179.","DOI":"10.1016\/j.neuint.2013.06.002"},{"key":"key-10.7555\/JBR.34.20200108-81","doi-asserted-by":"publisher","unstructured":"Fan JM, Fan XF, Li Y, et al.  Blunted inflammation mediated by NF-\u03baB activation in hippocampus alleviates chronic normobaric hypoxia-induced anxiety-like behavior in rats[J]. <i>Brain Res Bull, <\/i>2016, 122: 54\u201361.","DOI":"10.1016\/j.brainresbull.2016.03.001"},{"key":"key-10.7555\/JBR.34.20200108-82","doi-asserted-by":"publisher","unstructured":"Pesarico AP, Sartori G, Br\u00fcning CA, et al.  A novel isoquinoline compound abolishes chronic unpredictable mild stress-induced depressive-like behavior in mice[J]. <i>Behav Brain Res, <\/i>2016, 307: 73\u201383.","DOI":"10.1016\/j.bbr.2016.03.049"},{"key":"key-10.7555\/JBR.34.20200108-83","doi-asserted-by":"publisher","unstructured":"Zhu LJ, Ni HY, Chen R, et al.  Hippocampal nuclear factor kappa B accounts for stress-induced anxiety behaviors via enhancing neuronal nitric oxide synthase (nNOS)-carboxy-terminal PDZ ligand of nNOS-Dexras1 coupling[J]. <i>J Neurochem, <\/i>2018, 146(5): 598\u2013612.","DOI":"10.1111\/jnc.14478"},{"key":"key-10.7555\/JBR.34.20200108-84","doi-asserted-by":"publisher","unstructured":"Zhu LJ, Shi HJ, Chang L, et al.  nNOS-CAPON blockers produce anxiolytic effects by promoting synaptogenesis in chronic stress-induced animal models of anxiety[J]. <i>Br J Pharmacol, <\/i>2020, 177(16): 3674\u20133690.","DOI":"10.1111\/bph.15084"},{"key":"key-10.7555\/JBR.34.20200108-85","doi-asserted-by":"publisher","unstructured":"Liang HY, Chen ZJ, Xiao H, et al.  nNOS-expressing neurons in the vmPFC transform pPVT-derived chronic pain signals into anxiety behaviors[J]. <i>Nat Commun, <\/i>2020, 11(1): 2501.","DOI":"10.1038\/s41467-020-16198-5"},{"key":"key-10.7555\/JBR.34.20200108-86","doi-asserted-by":"publisher","unstructured":"Sumner JA, Edmondson D.  Refining our understanding of PTSD in medical settings[J]. <i>Gen Hosp Psychiatry, <\/i>2018, 53: 86\u201387.","DOI":"10.1016\/j.genhosppsych.2018.05.001"},{"key":"key-10.7555\/JBR.34.20200108-87","doi-asserted-by":"publisher","unstructured":"Milad M R, Quirk G J.  Fear extinction as a model for translational neuroscience: ten years of progress[J]. <i>Annu Rev Psychol, <\/i>2012, 63: 129\u2013151.","DOI":"10.1146\/annurev.psych.121208.131631"},{"key":"key-10.7555\/JBR.34.20200108-88","doi-asserted-by":"publisher","unstructured":"Burgos-Robles A, Vidal-Gonzalez I, Santini E, et al.  Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex[J]. <i>Neuron, <\/i>2007, 53(6): 871\u2013880.","DOI":"10.1016\/j.neuron.2007.02.021"},{"key":"key-10.7555\/JBR.34.20200108-89","doi-asserted-by":"publisher","unstructured":"Soliman F, Glatt CE, Bath KG, et al.  A genetic variant BDNF polymorphism alters extinction learning in both mouse and human[J]. <i>Science, <\/i>2010, 327(5967): 863\u2013866.","DOI":"10.1126\/science.1181886"},{"key":"key-10.7555\/JBR.34.20200108-90","doi-asserted-by":"publisher","unstructured":"Ji YY, Pang PT, Feng LY, et al.  Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons[J]. <i>Nat Neurosci, <\/i>2005, 8(2): 164\u2013172.","DOI":"10.1038\/nn1381"},{"key":"key-10.7555\/JBR.34.20200108-91","doi-asserted-by":"publisher","unstructured":"Cai CY, Chen C, Zhou Y, et al.  PSD-95-nNOS Coupling Regulates Contextual Fear Extinction in the Dorsal CA3[J]. <i>Sci Rep, <\/i>2018, 8(1): 12775.","DOI":"10.1038\/s41598-018-30899-4"},{"key":"key-10.7555\/JBR.34.20200108-92","doi-asserted-by":"publisher","unstructured":"Li J, Han Z, Cao B, et al.  Disrupting nNOS-PSD-95 coupling in the hippocampal dentate gyrus promotes extinction memory retrieval[J]. <i>Biochem Biophys Res Commun, <\/i>2017, 493(1): 862\u2013868.","DOI":"10.1016\/j.bbrc.2017.09.003"},{"key":"key-10.7555\/JBR.34.20200108-93","doi-asserted-by":"publisher","unstructured":"Kostek JA, Beck KD, Gilbertson MW, et al.  Acquired equivalence in U.S. veterans with symptoms of posttraumatic stress: reexperiencing symptoms are associated with greater generalization[J]. <i>J Trauma Stress, <\/i>2014, 27(6): 717\u2013720.","DOI":"10.1002\/jts.21974"},{"key":"key-10.7555\/JBR.34.20200108-94","doi-asserted-by":"publisher","unstructured":"Bian XL, Qin C, Cai CY, et al.  Anterior cingulate cortex to ventral hippocampus circuit mediates contextual fear generalization[J]. <i>J Neurosci, <\/i>2019, 39(29): 5728\u20135739.","DOI":"10.1523\/JNEUROSCI.2739-18.2019"},{"key":"key-10.7555\/JBR.34.20200108-95","doi-asserted-by":"publisher","unstructured":"Qin C, Bian XL, Cai CY, et al.  Uncoupling nNOS-PSD-95 in the ACC can inhibit contextual fear generalization[J]. <i>Biochem Biophys Res Commun, <\/i>2019, 513(1): 248\u2013254.","DOI":"10.1016\/j.bbrc.2019.03.184"},{"key":"key-10.7555\/JBR.34.20200108-96","doi-asserted-by":"publisher","unstructured":"Li LP, Dustrude ET, Haulcomb MM, et al.  PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSD[J]. <i>Transl Psychiatry, <\/i>2018, 8(1): 155.","DOI":"10.1038\/s41398-018-0208-5"},{"key":"key-10.7555\/JBR.34.20200108-97","doi-asserted-by":"publisher","unstructured":"Song S, Lee J, Park S, et al.  Fear renewal requires nitric oxide signaling in the lateral amygdala[J]. <i>Biochem Biophys Res Commun, <\/i>2020, 523(1): 86\u201390.","DOI":"10.1016\/j.bbrc.2019.12.038"},{"key":"key-10.7555\/JBR.34.20200108-98","doi-asserted-by":"publisher","unstructured":"Zou ZL, Wang HJ, d'Oleire Uquillas F, et al.  Definition of substance and non-substance addiction[J]. <i>Adv Exp Med Biol, <\/i>2017, 1010: 21\u201341.","DOI":"10.1007\/978-981-10-5562-1_2"},{"key":"key-10.7555\/JBR.34.20200108-99","doi-asserted-by":"publisher","unstructured":"Liu JF, Li JX.  Drug addiction: a curable mental disorder?[J]. <i>Acta Pharmacol Sin, <\/i>2018, 39(12): 1823\u20131829.","DOI":"10.1038\/s41401-018-0180-x"},{"key":"key-10.7555\/JBR.34.20200108-100","doi-asserted-by":"publisher","unstructured":"Leri F, Zhou Y, Goddard B, et al.  Effects of high-dose methadone maintenance on cocaine place conditioning, cocaine self-administration, and mu-opioid receptor mRNA expression in the rat brain[J]. <i>Neuropsychopharmacology, <\/i>2006, 31(7): 1462\u20131474.","DOI":"10.1038\/sj.npp.1300927"},{"key":"key-10.7555\/JBR.34.20200108-101","doi-asserted-by":"publisher","unstructured":"Schroeder JA, Niculescu M, Unterwald EM.  Cocaine alters mu but not delta or kappa opioid receptor-stimulated in situ [<sup>35<\/sup>S]GTP\u03b3S binding in rat brain[J]. <i>Synapse, <\/i>2003, 47(1): 26\u201332.","DOI":"10.1002\/syn.10148"},{"key":"key-10.7555\/JBR.34.20200108-102","doi-asserted-by":"publisher","unstructured":"Th\u00e9riault RK, Leri F, Kalisch B.  The role of neuronal nitric oxide synthase in cocaine place preference and mu opioid receptor expression in the nucleus accumbens[J]. <i>Psychopharmacology (Berl), <\/i>2018, 235(9): 2675\u20132685.","DOI":"10.1007\/s00213-018-4961-1"},{"key":"key-10.7555\/JBR.34.20200108-103","doi-asserted-by":"publisher","unstructured":"Itzhak Y, Anderson KL, Ali SF.  Differential response of nNOS knockout mice to MDMA (\"ecstasy\")- and methamphetamine-induced psychomotor sensitization and neurotoxicity[J]. <i>Ann N Y Acad Sci, <\/i>2004, 1025(1): 119\u2013128.","DOI":"10.1196\/annals.1316.015"},{"key":"key-10.7555\/JBR.34.20200108-104","doi-asserted-by":"publisher","unstructured":"Balda MA, Anderson KL, Itzhak Y.  Adolescent and adult responsiveness to the incentive value of cocaine reward in mice: role of neuronal nitric oxide synthase (nNOS) gene[J]. <i>Neuropharmacology, <\/i>2006, 51(2): 341\u2013349.","DOI":"10.1016\/j.neuropharm.2006.03.026"},{"key":"key-10.7555\/JBR.34.20200108-105","doi-asserted-by":"publisher","unstructured":"Koob GF, Volkow ND.  Neurocircuitry of addiction[J]. <i>Neuropsychopharmacology, <\/i>2010, 35(1): 217\u2013238.","DOI":"10.1038\/npp.2009.110"},{"key":"key-10.7555\/JBR.34.20200108-106","doi-asserted-by":"publisher","unstructured":"Smith ACW, Scofield MD, Heinsbroek JA, et al.  Accumbens nNOS interneurons regulate cocaine relapse[J]. <i>J Neurosci, <\/i>2017, 37(4): 742\u2013756.","DOI":"10.1523\/JNEUROSCI.2673-16.2016"},{"key":"key-10.7555\/JBR.34.20200108-107","doi-asserted-by":"publisher","unstructured":"Zou SL, Kumar U.  Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus[J]. <i>Brain Res, <\/i>2015, 1622: 114\u2013126.","DOI":"10.1016\/j.brainres.2015.06.021"},{"key":"key-10.7555\/JBR.34.20200108-108","doi-asserted-by":"publisher","unstructured":"Ribeiro EA, Salery M, Scarpa JR, et al.  Transcriptional and physiological adaptations in nucleus accumbens somatostatin interneurons that regulate behavioral responses to cocaine[J]. <i>Nat Commun, <\/i>2018, 9(1): 3149.","DOI":"10.1038\/s41467-018-05657-9"},{"key":"key-10.7555\/JBR.34.20200108-109","doi-asserted-by":"publisher","unstructured":"Kou XL, Tao Y, Xian JY, et al.  Uncoupling nNOS-PSD-95 in mPFC inhibits morphine priming-induced reinstatement after extinction training[J]. <i>Biochem Biophys Res Commun, <\/i>2020, 525(2): 520\u2013527.","DOI":"10.1016\/j.bbrc.2020.02.112"}],"container-title":["The Journal of Biomedical Research"],"original-title":[],"link":[{"URL":"http:\/\/www.jbr-pub.org.cn\/fileSWYXYJZZYWB\/journal\/article\/swyxyjzzywb\/2021\/1\/JBR-2020-0108.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T17:16:11Z","timestamp":1678382171000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbr-pub.org.cn\/article\/doi\/10.7555\/JBR.34.20200108?viewType=HTML"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"alternative-id":["JBR-2020-0108"],"URL":"https:\/\/doi.org\/10.7555\/jbr.34.20200108","relation":{},"ISSN":["1674-8301"],"issn-type":[{"value":"1674-8301","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}